Last reviewed · How we verify
To Evaluate the Effect of GnRH Agonist Administered in the Luteal Phase on ART Cycle Outcomes in Both GnRH Agonist and GnRH Antagonist Treated Ovarian Stimulation Protocols
This prospective clinical trial evaluates the effect of a two dose GnRH agonist administered in the luteal phase on the outcome of ART cycles stimulated with the long GnRH agonist and GnRH antagonist protocol.
Details
| Lead sponsor | Zekai Tahir Burak Women's Health Research and Education Hospital |
|---|---|
| Phase | NA |
| Status | UNKNOWN |
| Enrolment | 100 |
| Start date | 2014-04 |
| Completion | 2015-04 |
Conditions
- Infertility
Interventions
- Leuprolide acetate
- vaginal progesterone
- 4 mg oral estradiol valerate
Primary outcomes
- Live Birth Rate — 42 weeks
Countries
Turkey (Türkiye)